Dr. Frederick Lansigan, MD
- Medicare services, 2024
- 584
- Medicare patients, 2024
- 204
- Part D claims, 2024
- 380
- Publications
- 60
- Clinical trials
- 9
- Practice address
- 1 Medical Center Drive, Lebanon, NH 03756
- Practice phone
- Call (603) 650-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lansigan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Frederick Lansigan is a hematologist and oncologist in Lebanon, New Hampshire
Dr. Lansigan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.
Dr. Lansigan's NPI, 1548436520, was assigned on April 30, 2008. Dr. Lansigan graduated from SUNY Downstate Health Sciences University in 2002. Dr. Lansigan holds New Hampshire license 14513.
- NPI
- 1548436520NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6103971130
- NPI enumeration date
- April 30, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (603) 650-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Frederick Lansigan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire
Dr. Lansigan's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.
- Dartmouth Hitchcock Medical Center1 Medical Center Drive, Lebanon, NH 03756 · Grafton CountyPhone(603) 650-5000
Source: Dmand AI Affiliation Data
Dr. Frederick Lansigan is affiliated with 2 sites of care and 2 medical groups
Dr. Lansigan's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Lansigan is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Lansigan to 1 more medical group, named with a free account. Dr. Lansigan's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Frederick Lansigan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lansigan practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dartmouth Hitchcock Medical Center | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dartmouth-Hitchcock Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Frederick Lansigan is one of 67 hematologists and oncologists in New Hampshire
Hematology and oncology is Dr. Lansigan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lansigan is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lansigan's licenses on file in 4 states: New Hampshire, Maine, Connecticut and New York.
Specialties and state licenses
- Hematology and oncology, New HampshirePrimary
- Maine license
- Connecticut license
- New York license
Clinical focus
Dmand AI lists chronic anemia, chronic leukemia, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Lansigan treats.
Hematologists and oncologists near Dr. Lansigan
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Frederick Lansigan billed Medicare for 584 services in 2024
CMS data shows 584 Medicare services from Dr. Lansigan across 5 procedure codes in 2024, for 204 Medicare patients. Medicare paid $48,489 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Lansigan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3822024: 54342%
- Other services
- 2023: 02024: 41
Dr. Lansigan compared with the New Hampshire median for hematologists and oncologists, 2024
- Dr. Lansigan
- New Hampshire median
- Medicare services
- 584vs 576Close to median
- Medicare patients
- 204vs 24316% below
- Part D claims
- 294vs 21338% above
Medians across 65 hematologists and oncologists in New Hampshire with Dmand AI profiles that report each measure.
Dr. Lansigan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lansigan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lansigan and other hematologists and oncologists in New Hampshire.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Frederick Lansigan treated 204 Medicare patients in 2024, average age 74
CMS counts 204 Medicare patients who saw Dr. Lansigan in 2024. The largest group is 65 to 74, with 90 patients. 70% of them have high blood pressure, and 61% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lansigan's median patient age at 66, with 43% women.
Dr. Lansigan's Medicare patients by age, 2024
Dr. Lansigan's Medicare patients by sex, 2024
- Women9245%
- Men11255%
Chronic conditions among Dr. Lansigan's Medicare patients, 2024
- High blood pressure70%
- High cholesterol61%
- Arthritis35%
- Anxiety31%
- Mood disorders28%
- Chronic kidney disease25%
- Diabetes25%
- Ischemic heart disease25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lansigan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women43%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Frederick Lansigan wrote 380 Medicare Part D claims in 2024
In 2024, Dr. Lansigan wrote 380 Medicare Part D claims for 51 patients. 86% of them were for generic drugs. CMS names the drug for 294 of them, across 12 drugs with 11 or more claims each, at $484,187 in total drug cost. In 2023, CMS named 260 claims across 9 drugs.
Dr. Lansigan's Part D claims by kind of drug, 2024
- Generic327 claims86%
- Brand-name53 claims14%
Dr. Lansigan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Lansigan's Part D claims, 2024
- Antibiotics12%46 of 380 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2602024: 29413%
Drugs named by CMS: 12 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Frederick Lansigan scored 80 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Lansigan for performance year 2024, reported through an alternative payment model (APM). Dr. Lansigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lansigan as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Lansigan's MIPS scores, performance year 2024
- 80of 100Final score
- 53.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Frederick Lansigan has 60 publications on record
Dmand AI links 60 papers to Dr. Lansigan, published from 2008 to 2024. 2020 was the busiest year, with 9. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Leukemia, Lymphocytic, Chronic, B-Cell and Antineoplastic Agents. Dr. Lansigan has published most often in J Cutan Pathol. Dr. Lansigan's most frequent co-authors are Stephen J. Schuster, MD, John Nathan Allan, MD and Paul Michael Barr, MD.
Dr. Lansigan's papers by year, 2015 to 2024
Topics Dr. Lansigan writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Leukemia, Lymphocytic, Chronic, B-Cell
- Antineoplastic Agents
- Rituximab
- Skin Neoplasms
- Antibodies, Monoclonal
- Diagnosis, Differential
- Doxorubicin
Dr. Lansigan's most frequent co-authors
- Stephen J. Schuster, MD8 shared papers
- John Nathan Allan, MD7 shared papers
- Paul Michael Barr, MD7 shared papers
Recent publications by Dr. Lansigan
Cancer Res Commun
See who Dr. Lansigan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lansigan works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Frederick Lansigan has worked on 9 clinical trials
Dmand AI links Dr. Lansigan to 9 clinical trials, 3 of them phase 1/2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Lymphoma, Non-Hodgkin and Lymphoma, T-Cell, Cutaneous. Dartmouth-Hitchcock Medical Center sponsors the most, 4. Open Payments lists research payments to Dr. Lansigan that name 1 trial.
Clinical trials with Dr. Lansigan by phase
- NonePhase 1: no trials
- 3Phase 1/2: 3 trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Lansigan's trials
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell, Cutaneous
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Follicular
Investigators on the most trials with Dr. Lansigan
- Veronika Bachanova, MD2 shared trials
- Ryotaro Nakamura, MD2 shared trials
- John Nathan Allan, MD1 shared trial
Recent clinical trials with Dr. Lansigan
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (opens in a new tab)
Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL (opens in a new tab)
A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Frederick Lansigan received $48,368 in industry payments from 2016 to 2025
CMS Open Payments shows 106 general payments to Dr. Lansigan from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Seagen Inc. paid the most, $12,918. It also lists 4 research payments totaling $5,172 from 2016 to 2017, naming 1 clinical trial.
General payments to Dr. Lansigan by program year, 2016 to 2025
General payments to Dr. Lansigan by kind, 2016 to 2025
- Consulting fees$20,34342%
- Honoraria$11,00023%
- Travel and lodging$7,00314%
- Speaker and faculty fees$6,00012%
- Other$4,0238%
Companies that paid Dr. Lansigan the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Frederick Lansigan has 1 award and honors on record
Dmand AI lists 1 award for Dr. Lansigan, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Lansigan
- 2013
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Frederick Lansigan graduated from SUNY Downstate Health Sciences University
Dr. Lansigan graduated from SUNY Downstate Health Sciences University in 2002. Dr. Lansigan is a member of ASCO.
- Medical school
- Board certified in hematology
Source: Dmand AI Professional Profile Data
Dr. Frederick Lansigan accepts plans from 14 insurance carriers
Dr. Lansigan is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- Cigna
- Elevance
- HCSC
- +6 more carriersWith a free account
Plan types Dr. Lansigan accepts, by number of carriers
- PPO9
- Medicare8
- HMO7
- POS4
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Frederick Lansigan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Frederick Lansigan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Frederick Lansigan's NPI number?
Dr. Frederick Lansigan's NPI number is 1548436520. It was assigned on April 30, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Frederick Lansigan?
Dr. Frederick Lansigan is a hematologist and oncologist in Lebanon, New Hampshire. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Frederick Lansigan practice?
Dr. Lansigan practices at 1 Medical Center Drive, Lebanon, NH 03756. Dr. Lansigan's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dmand AI also links Dr. Lansigan to 1 medical group.
What is Dr. Frederick Lansigan's office phone number?
The practice phone on file for Dr. Lansigan is (603) 650-5000.
What is Dr. Frederick Lansigan's medical license number?
Dr. Lansigan holds New Hampshire license 14513, one of the licenses on file in 4 states.
Which states has Dr. Frederick Lansigan been licensed in?
Dmand AI has state licenses on file for Dr. Lansigan in New Hampshire (2009 to 2027), Maine (2020 to 2021), Connecticut (2006 to 2008) and New York (2004 to 2008).
Which hospitals is Dr. Frederick Lansigan affiliated with?
Dr. Lansigan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Lansigan is also affiliated with Cheshire Medical Center.
What medical group is Dr. Frederick Lansigan part of?
Dr. Lansigan is linked to Dartmouth Hitchcock Medical Center. Dmand AI links Dr. Lansigan to 1 more medical group.
Does Dr. Frederick Lansigan accept Medicare?
Yes. CMS data shows Dr. Lansigan billed Medicare for 584 services in 2024, and Dr. Lansigan accepts Medicare assignment.
Does Dr. Frederick Lansigan offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Lansigan as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Frederick Lansigan's MIPS score?
Dr. Lansigan's MIPS final score for performance year 2024 is 80 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Frederick Lansigan see?
CMS counts 204 Medicare patients who saw Dr. Lansigan in 2024, with an average age of 74.
Is Dr. Frederick Lansigan board certified?
Yes. Dr. Lansigan is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Frederick Lansigan bill to Medicare?
In 2024, Dr. Lansigan's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Frederick Lansigan go to medical school?
Dr. Lansigan graduated from SUNY Downstate Health Sciences University in 2002.
What drugs does Dr. Frederick Lansigan prescribe most?
In 2024 Medicare Part D data, Dr. Lansigan's most prescribed drugs by claims were Bexarotene, Acyclovir and Levothyroxine Sodium.
Has Dr. Frederick Lansigan received payments from drug or device companies?
CMS Open Payments shows $48,368 in general payments to Dr. Lansigan from 22 companies from 2016 to 2025. The largest total came from Seagen Inc.
How long has Dr. Frederick Lansigan been practicing?
Dr. Lansigan graduated from medical school in 2002, 24 years ago.
Does Dr. Frederick Lansigan do research?
Dmand AI links 60 publications to Dr. Lansigan, published from 2008 to 2024. Dr. Lansigan has worked on 9 clinical trials.
Who does Dr. Frederick Lansigan publish with?
Dr. Lansigan's most frequent co-authors are Stephen J. Schuster, MD (8 shared papers), John Nathan Allan, MD (7 shared papers) and Paul Michael Barr, MD (7 shared papers).
What insurance does Dr. Frederick Lansigan accept?
Dr. Lansigan is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in New Hampshire by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card